Three of Indonesia’s most restless volcanoes erupted within hours of one another on the night of August 18, 2026, sending ash ...

PERSIB renew their partnership for 2026, bringing exclusive programs, banking benefits and experiences to Bobotoh.

DBV Technologies Announces Sale of Approximately $50 Million of ADSs Through Its At-The-Market (ATM) Program on Nasdaq DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Capital Market: ...

With low valuations for the sector overall, follow-on common equity offerings for US real estate investment trusts have declined significantly in recent years. US equity REITs have largely preferred ...

Management reiterated its 45Z expectation, with CEO McGregor stating, "We remain on track to qualify 90 million gallons or more of combined production this year," supporting "our expectation for ...

Innodata's Q2 revenue surged 58% to $92.1M, beating estimates. It launched a $300M ATM program, while customer concentration eased. Innodata's $300 Million Share Sale Puts a Fine Point on a Week of ...

The company had held off buying Bitcoin before the sale, instead focusing on strengthening its cash balance. Bitcoin treasury Strategy on Monday announced that it had again sold a slice of its Bitcoin ...

Q2 2026 Gross Profit of $16.6 Million Increased $18.6 Million Q2 2026 Net Income of $11.4 Million, or $0.15 per Share, Improved $22.7 Million Q2 2026 Adjusted EBITDA of $23.7 Million Improved $23.9 ...

HARMONi-GU1 Is First Global Registrational Clinical Trial of Ivonescimab in a Genitourinary (GU) Cancer, Adding to Global Phase III Ivonescimab Studies in NSCLC and CRC Clinical Trial Site Activations ...

Summit Therapeutics Inc. (NASDAQ: SMMT) today announced the expansion of its global registration-enabling clinical development program for the novel, potential first-in-class investigational ...